Lyophilised peptide is stable for months to years when kept dry and cold. Once it goes into solution, the clock speeds up dramatically — degradation that took years in powder form can take weeks. Most loss of material integrity in a laboratory happens after reconstitution, and most of it is avoidable.
This is a handling reference: what to use as a solvent, how to add it, what storage conditions actually preserve a peptide, and which common practices quietly destroy samples.
Before you open the vial: let it reach room temperature
A vial taken from a −20 °C freezer and opened immediately will pull moisture from the air onto the cold powder. Lyophilised peptides are hygroscopic — they absorb atmospheric water readily — and introduced moisture starts hydrolysis in material that was meant to stay dry.
Let a sealed vial equilibrate to room temperature before breaking the seal. Twenty to thirty minutes is usually enough for a standard 2 mL vial. If the vial is cold to the touch, it isn’t ready.
This applies every time the vial is opened, not only the first time.
Choosing a solvent
Most research peptides dissolve in sterile water or bacteriostatic water. Solubility depends on the peptide’s sequence, and specifically on the charge its residues carry at neutral pH.
Start with water. For the majority of sequences, sterile or bacteriostatic water is sufficient and is the correct first attempt. Adding organic solvent or adjusting pH before it’s necessary introduces variables you then have to control for.
If the peptide does not dissolve, the sequence tells you what to try next:
| Peptide character | Typical behaviour | Reasonable next solvent |
|---|---|---|
| Basic (Lys, Arg, His rich) | Dissolves readily in water | Water; dilute acetic acid if slow |
| Acidic (Asp, Glu rich) | May resist neutral water | Small volume of dilute ammonium hydroxide, then dilute |
| Hydrophobic (Leu, Ile, Val, Phe rich) | Poor aqueous solubility | Minimal DMSO or acetonitrile, then dilute into buffer |
| Highly hydrophobic / aggregating | May gel or cloud | Denaturant or organic co-solvent; sonication |
The general principle is to dissolve in the smallest possible volume of the strongest appropriate solvent, then dilute into your working buffer — not the reverse. Adding buffer to an undissolved peptide often produces a suspension that looks dissolved and isn’t.
Bacteriostatic vs sterile water. Bacteriostatic water contains approximately 0.9% benzyl alcohol as a preservative, which inhibits microbial growth in a multi-use vial. Sterile water contains no preservative and is single-use once opened. For a solution that will be accessed repeatedly over days or weeks, bacteriostatic water reduces contamination risk — the trade-offs are covered in bacteriostatic vs sterile water. For single-use preparation, or where benzyl alcohol would interfere with a downstream assay, sterile water is the correct choice.
Adding the solvent
Technique matters more than people expect.
Direct the stream at the vial wall, not the powder cake. A jet of liquid hitting lyophilised material directly can cause localised aggregation and foaming. Letting the solvent run down the inside wall and pool underneath the cake dissolves it more gently and more completely.
Do not shake. Shaking introduces air, and the air–liquid interface is one of the more effective ways to denature a peptide. It also generates foam that traps material at the surface, so you lose some of what you paid for.
Swirl gently, or let it sit. Most peptides dissolve in a few minutes with occasional gentle swirling. Some take longer. Patience is cheaper than a re-order.
Look at the solution. A properly reconstituted peptide is clear and free of visible particulates. Cloudiness, visible strands, or a gel-like texture indicate incomplete dissolution or aggregation — the material is not ready to use and diluting it further will not fix it.
Storage: dry powder
Lyophilised peptide is far more stable than peptide in solution, and this is the form to keep material in for as long as possible.
| Condition | Practical storage life | Notes |
|---|---|---|
| −20 °C, desiccated, dark | Years for most sequences | Standard long-term condition |
| −80 °C, desiccated, dark | Longest | Preferred for extended archival storage |
| 4 °C, desiccated | Months | Acceptable short-term |
| Room temperature | Weeks | Transit-tolerable, not a storage condition |
Three conditions matter and all three are easy to get wrong:
Dry. Keep the desiccant. Moisture is the primary enemy of lyophilised material, and a vial stored in a frost-free freezer that cycles temperature will accumulate condensation over time.
Cold. −20 °C is sufficient for most sequences. −80 °C extends life further and is worth it for material you won’t use for months.
Dark. Peptides containing tryptophan, tyrosine, phenylalanine, methionine or cysteine are photosensitive. Amber vials or opaque storage protect them; clear vials on an open shelf do not.
Storage: after reconstitution
Once in solution, stability drops sharply and the useful window is measured in days to weeks rather than years.
Aliquot immediately. This is the single most valuable habit in peptide handling. Divide the reconstituted solution into single-use volumes before freezing, so you never freeze–thaw the same material twice.
Freeze–thaw cycling is cumulative and destructive. Each cycle forms ice crystals that mechanically disrupt peptide structure and concentrate solutes at the freezing front, driving aggregation. A solution thawed five times is not the same material it was on the first thaw, even if it still looks clear.
Typical solution stability:
| Condition | Rough window |
|---|---|
| 4 °C | Days — sequence dependent |
| −20 °C, aliquoted | Weeks to months |
| −80 °C, aliquoted | Months |
These are general figures. A sequence with an oxidation-prone methionine or a deamidation-prone Asn-Gly motif will degrade faster than a robust sequence under identical conditions.
Sequence features that reduce stability
Some peptides are simply more fragile, and knowing which is useful when planning storage.
- Methionine, cysteine, tryptophan — prone to oxidation. Minimise headspace air, avoid repeated opening, consider inert gas overlay for sensitive work.
- Asn-Gly and Asp-Gly motifs — prone to deamidation and isomerisation, accelerated at neutral to basic pH.
- N-terminal glutamine — can cyclise to pyroglutamate, changing mass and potentially activity.
- Free cysteine residues — can form intermolecular disulfides, producing dimers and higher aggregates.
None of these make a peptide unusable. They mean storage conditions and timeframes matter more, and that a certificate of analysis reflecting the material as shipped is more useful than one from an unrelated batch.
Practices that quietly cost you material
- Opening a cold vial. Covered above, and the most common single error.
- Vortexing at full speed. Shear and air entrainment. Gentle swirling is almost always sufficient.
- Storing the stock solution and drawing from it repeatedly. Every access is a contamination and freeze–thaw opportunity. Aliquot instead.
- Frost-free freezers for long-term storage. The defrost cycle repeatedly warms contents. A manual-defrost unit is better for anything archival.
- Assuming clear means intact. Aggregation and chemical degradation are frequently invisible. Time and conditions are more reliable indicators than appearance.
What documentation should accompany material
A batch-specific certificate of analysis should state the identity confirmation method and result, the purity figure and the method used to determine it, the batch or lot number, and the date of analysis. A COA that isn’t traceable to the specific vial in front of you doesn’t tell you about your material.
Every VANTA batch is assayed by an independent laboratory before release, and the batch COA is available on the Certificates of Analysis page. The same handling guidance applies across all research compounds we supply, including BPC-157.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics, 2000;203(1–2):1–60. doi:10.1016/S0378-5173(00)00423-3
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharmaceutical Development and Technology, 2007;12(5):505–523. doi:10.1080/10837450701481157
- Reubsaet JL, Beijnen JH, Bult A, van Maanen RJ, Marchal JA, Underberg WJ. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. Journal of Pharmaceutical and Biomedical Analysis, 1998;17(6–7):955–978. doi:10.1016/S0731-7085(98)00063-6
Related reading
- What a certificate of analysis actually verifies
- Understanding peptide purity: HPLC, MS, and what 99% means
- Sources & References
All VANTA products are supplied for laboratory research use only. They are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.